Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-12-135169
Filing Date
2012-03-28
Accepted
2012-03-27 20:49:01
Documents
7
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d297459d10ka.htm 10-K/A 23890
  Complete submission text file 0001193125-12-135169.txt   9769795

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT itmn-20111231.xml EX-101.INS 1872070
3 XBRL TAXONOMY EXTENSION SCHEMA itmn-20111231.xsd EX-101.SCH 93517
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itmn-20111231_cal.xml EX-101.CAL 90103
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itmn-20111231_def.xml EX-101.DEF 276870
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE itmn-20111231_lab.xml EX-101.LAB 687815
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itmn-20111231_pre.xml EX-101.PRE 540333
Mailing Address 3280 BAYSHORE BLVD BRISBANE CA 94005
Business Address 3280 BAYSHORE BLVD BRISBANE CA 94005 415 466 2200
INTERMUNE INC (Filer) CIK: 0001087432 (see all company filings)

EIN.: 943296648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-29801 | Film No.: 12718472
SIC: 2834 Pharmaceutical Preparations